Lifecare ASA (OSL:LIFE)
Norway · Delayed Price · Currency is NOK 0.2860
-0.0140 (-4.67%)
Jun 4, 2026, 3:44 PM CET
Lifecare ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.89 | 0.11 | 2.48 | 4.26 | 6.78 | - |
Other Revenue | 6.53 | 6.53 | 7.19 | 8.82 | 15.36 | 1.6 |
| 7.42 | 6.64 | 9.67 | 13.09 | 22.13 | 1.6 | |
Revenue Growth (YoY) | -19.95% | -31.34% | -26.10% | -40.88% | 1284.20% | -70.34% |
Gross Profit | 7.42 | 6.64 | 9.67 | 13.09 | 22.13 | 1.6 |
Selling, General & Admin | 29.8 | 30.61 | 33.45 | 23.77 | 10.43 | 1.47 |
Other Operating Expenses | 93.34 | 97.99 | 56.08 | 21.41 | 26.32 | 15.46 |
Operating Expenses | 131.82 | 136.6 | 94.45 | 48.44 | 39.04 | 17.53 |
Operating Income | -124.4 | -129.96 | -84.78 | -35.35 | -16.9 | -15.93 |
Interest Expense | -11.03 | -2.52 | -0.47 | -0.2 | -0 | -0 |
Interest & Investment Income | - | 1.11 | 2.61 | 0.89 | 0.37 | 0.02 |
Currency Exchange Gain (Loss) | -1.2 | -1.2 | 0.19 | -0.67 | -0.31 | - |
Other Non Operating Income (Expenses) | 11.82 | 11.82 | 8.97 | - | 0.17 | -0.06 |
Pretax Income | -136.88 | -120.76 | -73.48 | -35.32 | -16.67 | -15.98 |
Income Tax Expense | -0.5 | -0.56 | -0.74 | -0.12 | 0.53 | -0.1 |
Earnings From Continuing Operations | -136.38 | -120.2 | -72.74 | -35.21 | -17.2 | -15.88 |
Minority Interest in Earnings | 0.28 | 0.69 | 0.99 | -0.05 | - | - |
Net Income | -136.1 | -119.51 | -71.76 | -35.26 | -17.2 | -15.88 |
Net Income to Common | -136.1 | -119.51 | -71.76 | -35.26 | -17.2 | -15.88 |
Shares Outstanding (Basic) | 298 | 18 | 13 | 9 | 8 | 8 |
Shares Outstanding (Diluted) | 298 | 18 | 13 | 9 | 8 | 8 |
Shares Change (YoY) | 2043.20% | 37.46% | 37.84% | 18.10% | 3.99% | 20.55% |
EPS (Basic) | -0.46 | -6.81 | -5.62 | -3.81 | -2.19 | -2.11 |
EPS (Diluted) | -0.46 | -6.81 | -5.62 | -3.81 | -2.19 | -2.11 |
Free Cash Flow | -134.05 | -116.83 | -78.3 | -38.55 | -23.91 | -21.27 |
Free Cash Flow Per Share | -0.45 | -6.66 | -6.14 | -4.16 | -3.05 | -2.82 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -1677.47% | -1957.23% | -876.67% | -270.13% | -76.37% | -996.22% |
Profit Margin | -1835.15% | -1799.89% | -741.98% | -269.43% | -77.71% | -992.87% |
Free Cash Flow Margin | -1807.52% | -1759.53% | -809.66% | -294.56% | -108.04% | -1329.85% |
EBITDA | -121.84 | -126.54 | -82.2 | -33.39 | -14.62 | -15.33 |
EBITDA Margin | - | - | - | -255.13% | -66.05% | - |
D&A For EBITDA | 2.57 | 3.42 | 2.58 | 1.96 | 2.28 | 0.6 |
EBIT | -124.4 | -129.96 | -84.78 | -35.35 | -16.9 | -15.93 |
EBIT Margin | - | - | - | -270.13% | -76.37% | - |
Revenue as Reported | 6.64 | 6.64 | 9.67 | 13.09 | 22.13 | 1.6 |